Testing the Developmental Origins Hypothesis (CHIPS-Child)
CHIPS-Child:Testing the Developmental Origins Hypothesis
INTRODUCTION: CHIPS-Child is a parallel, ancillary study to the CHIPS randomized controlled trial (RCT). CHIPS is designed to determine whether 'less tight' control [target diastolic BP (dBP) 100mmHg] or 'tight' control [target dBP 85mmHg] of non-proteinuric hypertension in pregnancy is better for the baby without increasing maternal risk.
CHIPS-Child is a follow up study at 12 m corrected post-gestational age (± 2 m) limited to non-invasive examination [anthropometry, hair cortisol, buccal swabs for epigenetic testing and a maternal questionnaire about infant feeding practices and background]. Annual contact will be maintained in years 2-5 and contact will include annual parental measurement of the child's height, weight and waist circumference.
OBJECTIVE: To directly test, for the first time in humans, whether differential blood pressure (BP) control in pregnancy has developmental programming effects, independent of birthweight. We predict that, like famine or protein malnutrition, 'tight' (vs. 'less tight') control of maternal BP will be associated with fetal under-nutrition and effects will be consistent with developmental programming.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
INTRODUCTION: Growing evidence shows that reduced fetal growth rate is associated with adult cardiovascular risk markers (e.g., obesity) and disease, and evidence worldwide indicates that this relationship is independent of birthweight. The leading theory describes 'developmental programming' in utero leading to permanent alteration of the fetal genome. While those changes are adaptive in utero, they may be maladaptive postnatally.
OBJECTIVE: To directly test, for the first time in humans, whether differential blood pressure (BP) control in pregnancy has developmental programming effects, independent of birthweight. We predict that, like famine or protein malnutrition, 'tight' (vs. 'less tight') control of maternal BP will be associated with fetal under-nutrition and effects will be consistent with developmental programming.
METHODS: CHIPS-Child is a parallel, ancillary study to the CHIPS randomized controlled trial (RCT). CHIPS is designed to determine whether 'less tight' control [target diastolic BP (dBP) 100mmHg] or 'tight' control [target dBP 85mmHg] of non-proteinuric hypertension in pregnancy is better for the baby without increasing maternal risk.
CHIPS-Child is a follow up study at 12 m corrected post-gestational age (± 2 m) limited to non-invasive examination [anthropometry, hair cortisol, buccal swabs for epigenetic testing and a maternal questionnaire about infant feeding practices and background]. Annual contact will be maintained in years 2-5 and contact will include annual parental measurement of the child's height, weight and waist circumference.
Sample size:. CHIPS will recruit 1028 women. We estimate that 80% of CHIPS centres will participate in CHIPS-Child, approximately 97% of babies will survive, and 90% of children will be followed to 12 m resulting in a sample size of 626. Power will be >80% to detect a between-group difference of ≥0.25 in 'change in z-score for weight' between birth and 12 m (2-sided alpha=0.05, SD 1).
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
-
Ipswich, Australie
- Recrutement
- Ipswich Hospital
-
Subiaco, Australie
- Recrutement
- King Edward Memorial Hospital
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada
- Recrutement
- Royal Alexandra Hospital
-
-
British Columbia
-
Surrey, British Columbia, Canada
- Recrutement
- Surrey Memorial Hospital: Jim Pttison Outpatient Care & Surgery Centre
-
Vancouver, British Columbia, Canada, V6H 3N1
- Recrutement
- BC Children & Women's Health Centre
-
Chercheur principal:
- Laura A Magee, MD FRCPC MSc
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada
- Recrutement
- IWK Health Centre
-
-
Ontario
-
London, Ontario, Canada
- Recrutement
- London Health Sciences Centre
-
Sherbrooke, Ontario, Canada
- Recrutement
- CHUS Fleurimont
-
Toronto, Ontario, Canada
- Recrutement
- Sunnybrook Health Sciences Centre
-
-
Quebec
-
Montreal, Quebec, Canada
- Recrutement
- Hopital Sainte-Justine
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada
- Recrutement
- Royal University Hospital
-
-
-
-
-
Osorno, Chili
- Recrutement
- Hospital Base Osorno
-
Puente Alto, Chili
- Recrutement
- Hospital Dr Sotero del Rio
-
-
-
-
-
Tartu, Estonie
- Recrutement
- Tartu University Hospital - Women's Clinic
-
-
-
-
-
Christchurch, Nouvelle-Zélande
- Recrutement
- Christchurch Women's Hospital
-
-
-
-
-
Amsterdam, Pays-Bas
- Recrutement
- OLVG
-
Amsterdam, Pays-Bas
- Recrutement
- Academic Medical Center
-
Amsterdam, Pays-Bas
- Recrutement
- VU Medical Center
-
Groningen, Pays-Bas
- Recrutement
- UMCG
-
Hilversum, Pays-Bas
- Recrutement
- Tergooiziekenhuizen
-
Maastricht, Pays-Bas
- Recrutement
- MUMC Maastricht
-
Nieuwegein, Pays-Bas
- Recrutement
- St Antonius Ziekenhuis
-
Utrecht, Pays-Bas
- Recrutement
- UMCU
-
Utrecht, Pays-Bas
- Recrutement
- Diakonessen Ziekenhuis
-
Veldhoven, Pays-Bas
- Recrutement
- Maxima Medical Centre
-
Zwolle, Pays-Bas
- Recrutement
- Isala Klinieken Zwolle
-
-
-
-
-
Birmingham, Royaume-Uni
- Recrutement
- Birmingham Women's Hospital
-
Bradford, Royaume-Uni
- Recrutement
- Bradford Royal Infirmary
-
Lancaster, Royaume-Uni
- Recrutement
- Royal Lancaster Infirmary
-
Newcastle Upon Tyne, Royaume-Uni
- Recrutement
- Royal Victoria Infirmary
-
Nottingham, Royaume-Uni
- Recrutement
- Nottingham City Hospital
-
Ormskirk, Royaume-Uni
- Recrutement
- Southport & Ormskirk Hospital
-
Plymouth, Royaume-Uni
- Recrutement
- Derriford Hospital
-
Sunderland, Royaume-Uni
- Recrutement
- City Hospitals Sunderland NHS Foundation Trust
-
Swansea, Royaume-Uni
- Recrutement
- Singleton Hospital
-
Wolverhampton, Royaume-Uni
- Recrutement
- New Cross Hospital
-
York, Royaume-Uni
- Recrutement
- York District Hospital
-
-
-
-
Connecticut
-
New Haven, Connecticut, États-Unis, 06510
- Recrutement
- Yale-New Haven Hospital
-
-
Kentucky
-
Louisville, Kentucky, États-Unis, 40202
- Recrutement
- Norton Hospital Downtown & Suburban
-
-
New Jersey
-
Camden, New Jersey, États-Unis, 08103
- Recrutement
- Copper University Hospital
-
-
Oregon
-
Portland, Oregon, États-Unis, 97239
- Recrutement
- Oregon Health & Science University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- All women participating in CHIPS and their children born after recruitment.
Exclusion Criteria:
- Women who have experienced the loss of their pregnancy or child after recruitment into CHIPS.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Tight
Children born to women in the CHIPS RCT randomized to "Tight" blood pressure control [target diastolic BP 85mmHg]
|
|
Less Tight
Children born to women in the CHIPS RCT randomized to "Less Tight" [target diastolic BP 100mmHg].
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
difference in 'change in z score for weight' at 12 m(+/- 2m)
Délai: birth to 12m (+/-2m) of age, 24m, 36m, 48m, 60m
|
Between-group difference in early postnatal weight gain ('change in z score for weight') between birth and 12 m (p<0.05),
24m, 36m, 48m & 60m.
|
birth to 12m (+/-2m) of age, 24m, 36m, 48m, 60m
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
hypothalamic pituitary adrenal axis function
Délai: average of 12m (+/-2m) of age
|
Hair collected at 12m (+/-2m) of age will be analysed for hypothalamic pituitary adrenal axis function (hair cortisol for overall cortisol production).
|
average of 12m (+/-2m) of age
|
|
differences in DNA methylation
Délai: average of 12 m (+/- 2m) of age
|
Buccal swab samples collected at 12m (+/-2m) of age will be assessed for between-groups differences in DNA methylation, using targeted (genes associated with growth, obesity, cardiovascular disease, and/or a developmental programming effect) and global (genome-wide microarray) methods.
|
average of 12 m (+/- 2m) of age
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Laura A Magee, MD, BC Children & Women's Health Centre
Publications et liens utiles
Publications générales
- Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009 Nov 1;18(21):4046-53. doi: 10.1093/hmg/ddp353. Epub 2009 Aug 4.
- Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009 Sep;27(5):358-68. doi: 10.1055/s-0029-1237424. Epub 2009 Aug 26.
- Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr. 2007;27:363-88. doi: 10.1146/annurev.nutr.27.061406.093705.
- Gilbert EF, Varakis J, Opitz JM, ZuRhein GM, Ware R, Viseskul C, Kaveggia EG, Hartmann HA. Generalized gangliosidosis type II (juvenile GM1 gangliosidosis). A pathological, histochemical and ultrastructural study. Z Kinderheilkd. 1975 Sep 11;120(3):151-80. doi: 10.1007/BF00439006.
- Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol. 2005 Sep-Oct;20(3):345-52. doi: 10.1016/j.reprotox.2005.04.005.
- Silveira PP, Portella AK, Goldani MZ, Barbieri MA. Developmental origins of health and disease (DOHaD). J Pediatr (Rio J). 2007 Nov-Dec;83(6):494-504. doi: 10.2223/JPED.1728.
- Cameron N, Demerath EW. Critical periods in human growth and their relationship to diseases of aging. Am J Phys Anthropol. 2002;Suppl 35:159-84. doi: 10.1002/ajpa.10183.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- H08-00882CHIPS-Child
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .